Avacopan Noninferior to Prednisone for ANCA-Associated Vasculitis

THURSDAY, Feb. 18, 2021 -- Avacopan is noninferior, but not superior, to prednisone with respect to remission at week 26 for patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, according to a study published in the Feb....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news